Background
Methods
Isolation and identification of staphylococcal isolatess
Antibiotic susceptibility testing
DNA extraction
PCR detection of the tufgene
PCR detection of the dfrAgene
SCCmectyping
Detection of the PVL gene
Genotyping
Results
Identification and source of the staphylococcal isolates
Isolate No | Location | Sample Or Clinical Diagnosis | Antibiogram |
tuf gene |
mecA gene |
dfrA gene | SCCmec typing | PVL gene |
spa type | MLST (ST) | Clonal Complex (CC) |
---|---|---|---|---|---|---|---|---|---|---|---|
50 | Lagos1 | Burns | PEN, OXA, GEN, CIP, MOX, ERY, CLI*, TET, COT, RIF | + | + | + | III | - | t037 | ST241 | CC8 |
2496ψ
| Maiduguri | GTI | PEN, OXA, GEN, CIP, ERY, CLI, TET, COT | + | + | - | NT/UNT | - | t037** | ||
2589 | Maiduguri | GTI | PEN, OXA, GEN, CIP, ERY, CLI, TET, COT | + | + | - | NT | - | t037 | ||
60ψ
| Lagos1 | ASOM | PEN, OXA, TET, COT | + | + | - | NT/V | - | t064** | ST8 | CC8 |
69¶
| Lagos1 | Nasal swab/Screening | PEN, OXA, GEN, TET, COT | + | + | - | NT | - | t064 | ||
T39sB | Iwo | HIV/AIDS | PEN, OXA, TET, COT | + | + | - | NT | - | t064 | ||
T6530 | Ile-Ife | Osteomyelitis | PEN, OXA, GEN, CIP, TET, COT | + | + | - | IV | - | t064 | ||
TU32 | Ibadan | Wound Infection | PEN, OXA, CIP, TET, COT | + | + | - | NT | - | t064 | ||
TU3ψ
| Ibadan | Wound Infection | PEN, OXA, CIP, TET, COT | + | + | - | NT/V | - | t064 | ||
T5056 | Ile-Ife | Bronchitis | PEN, OXA, GEN, CIP, ERY, CLI*, TET, COT, FUS, RIF | + | + | - | III | - | t074 | ST37 | CC30 |
TD17 | Ile-Ife | Bronchitis | PEN, OXA, ERY, CLI | + | + | ND | II | - | t007 | ST39 | |
TN45 | Ile-Ife | Wound Infection | PEN, OXA, TET | + | + | ND | IV | - | t729 | ST88 | CC88 |
003B | Maiduguri | Septicaemia | PEN, OXA, TET, COT | + | + | + | IV | - | t1603 | ||
008 | Maiduguri | Septicaemia | PEN, OXA, COT | + | + | + | IV | - | t1603 | ||
T5843ψ
| Ile-Ife | Osteomyelitis | PEN, OXA, TET, COT | + | + | - | NT/UNT | + | t4690** | ST152 | singleton |
Isolate No | Location | Sample Or Clinical Diagnosis | Antibiotype |
tufgene |
dfrAgene | PVL gene |
spatype | MLST (ST) | Clonal Complex (CC) |
---|---|---|---|---|---|---|---|---|---|
1229 | Maiduguri | GTI | TET | + | ND | - | t311 | ST5 | CC5 |
652 | Maiduguri | Not available | PEN, COT | + | - | + | t311 | ||
47 | Lagos1 | Leg Ulcer | PEN, TET, CIP, MOX, COT | + | - | - | t064 | CC8 | |
54 | Lagos1 | SLE | PEN, TET, COT, CIP | + | - | - | t064 | ||
49¶
| Lagos1 | Nasal swab/screening | PEN, COT | + | - | - | t2331** | ST8 | |
10 | Ogbomosho | SSI | PEN | + | ND | + | t084 | CC15 | |
62 | Lagos1 | UTI | COT | + | - | - | t084 | ||
076 | Maiduguri | Not available | PEN, TET, COT | + | - | - | t084 | ||
373 | Maiduguri | UTI | COT, TET | + | - | - | t084** | ST15 | |
1253 | Maiduguri | SSI | PEN, TET, COT | + | - | - | t084 | ||
2290 | Maiduguri | SSI | PEN, TET, COT | + | - | - | t084 | ||
2696 | Maiduguri | Semen (Infertility) | PEN, COT | + | - | - | t084 | ||
1038 | Maiduguri | SSI | PEN, COT | + | - | + | t2216 | ||
2478 | Maiduguri | UTI | PEN, TET, COT | + | - | - | t2216 | ||
6B | Ogbomosho | Septicaemia | COT | + | - | + | t318 | ST30 | CC30 |
51¶
| Lagos1 | Nasal swab/screening | PEN, COT | + | - | - | t318 | ||
1059 | Maiduguri | GTI | COT | + | - | - | t318 | ||
2578 | Maiduguri | GTI | PEN, TET, COT | + | - | + | t934 | ST80 | CC80 |
56 | Lagos1 | Otitis media | PEN, COT | + | - | - | t159 | ST121 | CC121 |
67¶
| Lagos1 | Nasal swab/screening | PEN, TET, COT | + | - | + | t2304 | ||
68¶
| Lagos1 | Nasal swab/screening | PEN, TET, COT | + | - | + | t2304 | ||
006 | Maiduguri | Septicaemia | PEN, TET, COT | + | - | + | t355** | ST152 | singleton |
0017 | Maiduguri | Septicaemia | PEN, TET, COT | + | - | + | t355 | ||
1097 | Maiduguri | SSI | PEN, TET, COT | + | - | + | t355 | ||
2365 | Maiduguri | Semen (Infertility) | PEN, COT | + | - | + | t355 | ||
259 | Maiduguri | Semen (Infertility) | PEN, COT | + | - | + | t355 | ||
604 | Maiduguri | SSI | PEN, TET, COT | + | - | - | t355 | ||
642 | Maiduguri | SSI | PEN, TET | + | ND | + |
t9008** | ||
829 | Maiduguri | SSI | PEN, TET | + | ND | - |
t9008
| ||
J11 | Jos | Septicaemia | PEN, TET, COT | + | - | + | t355 | ||
J13 | Jos | Septicaemia | PEN, TET, COT | + | - | + | t355 | ||
61 | Lagos1 | SSI | TET, COT | + | - | + |
t8987** | ||
64¶
| Lagos1 | Nasal swab/screening | PEN | + | ND | - | t1510 | ST508 | CC45 |
55 | Lagos1 | CSOM | PEN | + | ND | - | t8223 | ND | CC45 |
57 | Lagos1 | Haematoma | Susceptible to all antibiotics | + | ND | - | t635 | ND | ND |
70¶
| Lagos1 | Nasal swab/screening | PEN, TET, COT | + | - | - | NT | ND | ND |
Isolate No | Location | Sample/Clinical Condition | VITEK 2 Identification | Antibiogram |
mecA gene | SCCmec Typing |
---|---|---|---|---|---|---|
2 | Ogbomosho | Wound Infection |
S. saprophyticus
| PEN, TET, COT, FUS | - | ND |
4 | Ogbomosho | UTI |
S. saprophyticus
| PEN, TET, COT, FUS | - | ND |
7 | Ogbomosho | Osteomyelitis |
S. saprophyticus
| PEN, TET, COT, FUS | - | ND |
13B | Ogbomosho | UTI |
S. saprophyticus
| PEN, COT, FUS | - | ND |
14ψ
| Ogbomosho | Septicaemia |
S. sciuri
| PEN, OXA, GEN, CIP, FUS, MOX | + | NT/UNT |
16 | Ogbomosho | SSI |
S. warneri
| PEN, TET, COT, FUS | - | ND |
16B | Ogbomosho | Osteomyelitis |
S. warneri
| TET, COT, FUS | - | ND |
18 | Ogbomosho | SSI |
S. saprophyticus
| PEN, TET, COT, FUS | - | ND |
66 | Lagos2 | Wound Infection |
S. sciuri
| PEN, OXA, GEN, CIP, FUS | + | NT |
L2ψ
| Lagos2 | Septicaemia |
S. haemolyticus
| PEN, OXA, TET, COT | + | NT/V |
L5 | Lagos2 | Eye swab |
S. haemolyticus
| PEN, OXA, CIP, MOX, TET, COT | + | NT |
L6 | Lagos2 | Septicaemia |
S. haemolyticus
| PEN, OXA, GEN, CIP, ERY, TET, RIF, COT | + | NT |
L7 | Lagos2 | Septicaemia |
S. haemolyticus
| PEN, OXA, GEN, CIP, MOX, ERY, TET, COT | + | NT |
L8 | Lagos2 | Septicaemia |
S. haemolyticus
| PEN, OXA, GEN, CIP, ERY, CLI*, TET, COT | + | NT |
L9 | Lagos2 | Septicaemia |
S. haemolyticus
| PEN, OXA, GEN, CIP, TET, COT | + | NT |
L10 | Lagos2 | Eye swab |
S. haemolyticus
| PEN, OXA, GEN, CIP, MOX, ERY, TET, COT | + | NT |
1103 | Maiduguri | Wound Infection |
S. warneri
| PEN, OXA, TET | + | NT |
1268 | Maiduguri | Wound Infection |
S. haemolyticus
| PEN, OXA, GEN, CIP, MOX, TET, COT | + | NT |
024ψ
| Maiduguri | Wound Infection |
S. haemolyticus
| PEN, OXA, GEN, TET, COT | + | NT/V |
2491 | Maiduguri | UTI |
S. haemolyticus
| PEN, OXA, GEN, CIP, ERY, TET, COT, TEICOi | + | NT |
2412 | Maiduguri | Wound Infection |
S. haemolyticus
| PEN, OXA, GEN, CIP, MOX, TET, COT | + | NT |
2362 ψ
| Maiduguri | GTI |
S. haemolyticus
| PEN, OXA, GEN, CIP, ERY, CLI*, TET, COT | + | NT/UNT |
825 | Maiduguri | GTI |
S. haemolyticus
| PEN, OXA, GEN, CIP, TET, COT | + | NT |
2502 | Maiduguri | UTI |
S. haemolyticus
| PEN, OXA, GEN, COT | ND | ND |
J2 | Jos | Septicaemia |
S. hominis
| PEN, OXA, TET | ND | ND |
J5 | Jos | Septicaemia |
S. haemolyticus
| PEN, OXA, GEN, CIP, ERY, CLI*, TET, RIF, COT | ND | ND |
J6 | Jos | Septicaemia |
S. haemolyticus
| PEN, OXA, GEN, CIP, ERY, CLI*, TET, RIF, COT | ND | ND |
J10 | Jos | Septicaemia |
S. haemolyticus
| PEN, OXA, GEN, CIP, ERY, CLI*, TET, RIF, COT | ND | ND |
J14ψ
| Jos | Septicaemia |
S. haemolyticus
| PEN, OXA, GEN, CIP, ERY, TET, FUS, COT | + | NT/V |
J15 | Jos | Prostatis |
S. haemolyticus
| PEN, OXA, TET, COT | + | NT |
J16 | Jos | Otitis media |
S. haemolyticus
| PEN, OXA, GEN, CIP, COT | + | NT |
J17B | Jos | Osteomyelitis |
S. epidermidis
| PEN, OXA, COT | + | NT |
151 | Ogbomosho | Septicaemia |
S. haemolyticus
| PEN, OXA, GEN, CIP, MOX, TET, COT | + | NT |
12 | Ogbomosho | Conjunctivitis |
S. sciuri
| PEN, OXA, GEN, CIP, FUS | + | NT |
19B | Ogbomosho | SSI |
S. sciuri
| PEN, OXA, GEN, CIP, TET, FUS | + | NT |
11 | Ogbomosho | Wound abscess |
S. sciuri
| PEN, OXA, GEN, CIP, FUS | + | NT |
17 | Ogbomosho | Wound infection |
S. sciuri
| PEN, OXA, CIP, GEN, FUS | + | NT |
11B | Ogbomosho | UTI |
S. sciuri
| PEN, OXA, GEN, CIP, MOX, FUS | + | NT |
15 | Ogbomosho | UTI |
S. sciuri
| PEN, OXA, GEN, CIP, MOX, FUS | + | NT |
6 | Ogbomosho | UTI |
S. sciuri
| PEN, OXA, GEN, CIP, FUS | + | NT |
Antibiotic susceptibility of the staphylococcal isolates and detection of mecA and dfrAgenes
Number (%) of isolates resistant among | ||||
---|---|---|---|---|
Antibiotics | MSSA | MRSA |
S. haemolyticus
| Others (CNS) |
n=36 | n=15 | n=21 | n=19 | |
Penicillin | 29 (80.6) | 15 (100) | 21 (100) | 18 (94.7) |
Oxacillin | 0 (0) | 15 (100) | 21 (100) | 12 (63.2) |
Teicoplanin | 0 (0) | 0 (0) | 1* (4.8) | 0 (0) |
Vancomycin | 0 (0) | 0 (00 | 0 (0) | 0 (0) |
Gentamicin | 0 (0) | 6 (40) | 18 (85.7) | 9 (47.4) |
Tetracycline | 21 (58.3) | 13 (86.7) | 19 (90.5) | 9 (47.4) |
Ciprofloxacin | 2 (5.6) | 7 (46.7) | 17 (80.9) | 9 (47.4) |
Moxifloxacin | 1 (2.8) | 1 (6.7) | 6 (28.6) | 3 (15.8) |
Erythromycin | 0 (0) | 5 (33.3) | 10 (47.6) | 0 (0) |
Clindamycin | 0 (0) | 5 (33.3) | 5 (23.8) | 0 (0) |
Fusidic acid | 0 (0) | 1 (6.7) | 1 (4.8) | 16 (84.2) |
Tigecycline | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
Mupirocin | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
Linezolid | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
Rifampicin | 0 (0) | 2 (13.3) | 4 (19) | 0 (0) |
Cotrimoxazole | 29 (80.6) | 13 (86.7) | 21 (100) | 8 (42.1) |